loadpatents
name:-0.034656047821045
name:-0.020287990570068
name:-0.0027129650115967
Lin; Xichen Patent Filings

Lin; Xichen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Xichen.The latest application filed is for "heterocyclic glp-1 agonists".

Company Profile
2.20.33
  • Lin; Xichen - Shanghai CN
  • Lin; Xichen - King of Prussia PA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterocyclic Glp-1 Agonists
App 20220213130 - Meng; Qinghua ;   et al.
2022-07-07
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors
Grant 10,336,719 - Chen , et al.
2019-07-02
Novel Compounds
App 20190010135 - Chen; Weichun ;   et al.
2019-01-10
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors
Grant 10,106,515 - Chen , et al. October 23, 2
2018-10-23
Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases
Grant 10,005,731 - Han , et al. June 26, 2
2018-06-26
Heteroaryl substituted compounds as ROR.gamma. inhibitors
Grant 9,902,735 - Deng , et al. February 27, 2
2018-02-27
Compounds
Grant 9,902,715 - Deng , et al. February 27, 2
2018-02-27
Compounds
Grant 9,868,724 - Lei , et al. January 16, 2
2018-01-16
Novel Compounds
App 20170197978 - DENG; Jing ;   et al.
2017-07-13
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea Derivatives As Cxcr2 Inhibitors
App 20170190681 - CHEN; Weichun ;   et al.
2017-07-06
Novel Compounds
App 20170121313 - DENG; Jing ;   et al.
2017-05-04
Novel Compounds
App 20170101399 - LEI; Hui ;   et al.
2017-04-13
Modulators Of The Retinoid-related Orphan Receptor Gamma (ror-gamma) For Use In The Treatment Of Autoimmune And Inflammatory Diseases
App 20150299121 - HAN; Fangbin ;   et al.
2015-10-22
Heterocyclic compounds
Grant 8,389,508 - Deng , et al. March 5, 2
2013-03-05
7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
Grant 8,354,416 - Callahan , et al. January 15, 2
2013-01-15
Chemical compounds
Grant 8,354,406 - Deng , et al. January 15, 2
2013-01-15
Pyrimidine Derivatives For Use As Sphingosine 1-phosphate 1 (s1p1) Receptor Agonists
App 20130012491 - Lin; Xichen ;   et al.
2013-01-10
Oxadiazole Substituted Indazole Derivatives For Use As Sphingosine 1-phosphate 1 (s1p1) Receptor Agonists
App 20120283297 - Bailey; James ;   et al.
2012-11-08
1,2,4-oxadiazole indole compounds
Grant 8,217,028 - Castro Pineiro , et al. July 10, 2
2012-07-10
Compounds
Grant 8,207,176 - Callahan , et al. June 26, 2
2012-06-26
5-membered Heteroaryl Derivatives Used As Sphingosine 1- Phosphate Receptor Agonists
App 20120101136 - Deng; Guanghui ;   et al.
2012-04-26
5-membered Heteroaryl Derivatives Used As Sphingosine 1-phosphate Receptor Agonists
App 20120101134 - Deng; Guanghui ;   et al.
2012-04-26
Compounds
App 20120101123 - Li; Chengyong ;   et al.
2012-04-26
1,2,4-oxadiazol Derivatives, Their Pharmaceutical Compositions And Their Use As Sphingosine 1-phosphate 1 Receptor Agonists
App 20120101124 - Lin; Xichen ;   et al.
2012-04-26
Thiazole Or Thiadizaloe Derivatives For Use As Sphingosine 1-phosphate 1 (s1p1) Receptor Agonists
App 20120094979 - Bailey; James Matthew ;   et al.
2012-04-19
Indole Carboxamides As Ikk2 Inhibitors
App 20120040958 - Boehm; Jeffrey Charles ;   et al.
2012-02-16
Chemical Compounds
App 20120035164 - DENG; Jianghe ;   et al.
2012-02-09
Indole carboxamides as IKK2 inhibitors
Grant 8,071,584 - Boehm , et al. December 6, 2
2011-12-06
Compounds
App 20110269738 - Deng; Guanghui ;   et al.
2011-11-03
Compounds
App 20110086839 - Castro Pineiro; Jose Luis ;   et al.
2011-04-14
Chemical compounds
Grant 7,858,796 - Kerns , et al. December 28, 2
2010-12-28
Indole Carboxamides As Ikk2 Inhibitors
App 20100130468 - Boehm; Jeffrey Charles ;   et al.
2010-05-27
Novel Compounds
App 20100093765 - CALLAHAN; James F. ;   et al.
2010-04-15
Novel Compounds
App 20100093766 - CALLAHAN; James F. ;   et al.
2010-04-15
Compounds
Grant 7,678,801 - Callahan , et al. March 16, 2
2010-03-16
Compounds
Grant 7,674,789 - Callahan , et al. March 9, 2
2010-03-09
Compounds
App 20100029729 - Castro Pineiro; Jose Luis ;   et al.
2010-02-04
Compounds
App 20100010053 - Castro Pineiro; Jose Luis ;   et al.
2010-01-14
Novel Compounds
App 20090239846 - Callahan; James F. ;   et al.
2009-09-24
Novel Compounds
App 20090239897 - BOEHM; JEFFREY CHARLES ;   et al.
2009-09-24
Compounds
Grant 7,550,480 - Boehm , et al. June 23, 2
2009-06-23
Novel Compounds
App 20090156597 - Callahan; James F. ;   et al.
2009-06-18
Chemical Compounds
App 20090143372 - Deng; Jianghe ;   et al.
2009-06-04
Novel Compounds
App 20090069318 - Callahan; James Francis ;   et al.
2009-03-12
Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives
App 20090048444 - Callahan; James F. ;   et al.
2009-02-19
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
Grant 7,479,558 - Callahan , et al. January 20, 2
2009-01-20
Chemical Compounds
App 20080262040 - Callahan; James Francis ;   et al.
2008-10-23
Chemical Compounds
App 20080242685 - Kerns; Jeffrey K. ;   et al.
2008-10-02
Chemical Compounds
App 20070254873 - Kerns; Jeffrey K. ;   et al.
2007-11-01
Novel compounds
App 20060211727 - Boehm; Jeffrey Charles ;   et al.
2006-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed